Related Experiment Video
Updated: May 1, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Plant-derived epigenetic modulators for cancer treatment and prevention
Michael Schnekenburger1, Mario Dicato1, Marc Diederich2
1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, rue Edward Steichen, L-2540 Luxembourg, Luxembourg.
Abstract:
Carcinogenesis is a complex and multistep process that involves the accumulation of successive transformational events driven by genetic mutations and epigenetic alterations that affect major cellular processes and pathways such as proliferation, differentiation, invasion and survival. Massive deregulation of all components of the epigenetic machinery is a hallmark of cancer. These alterations affect normal gene regulation and impede normal cellular processes including cell cycle, DNA repair, cell growth, differentiation and apoptosis. Since epigenetic alterations appear early in cancer development and represent potentially initiating events during carcinogenesis, they are considered as promising targets for anti-cancer interventions by chemopreventive and chemotherapeutic strategies using epigenetically active agents. In this field, plant-derived compounds have shown promise. Here, we will give an overview of plant-derived compounds displaying anticancer properties that interfere with the epigenetic machinery.
Insights
Epigenetic alterations are key drivers of cancer development. Plant-derived compounds show promise as anticancer agents by targeting these epigenetic changes.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- Carcinogenesis is a multistep process involving genetic mutations and epigenetic alterations.
- Epigenetic deregulation is a hallmark of cancer, affecting crucial cellular processes.
- Epigenetic alterations are early events in cancer, making them targets for intervention.
Purpose of the Study:
- To provide an overview of plant-derived compounds with anticancer properties.
- To highlight compounds that interfere with the epigenetic machinery.
- To explore the potential of epigenetically active agents in cancer therapy.
Main Methods:
- Literature review of plant-derived compounds and their epigenetic mechanisms.
- Analysis of studies demonstrating anticancer effects of these compounds.
- Focus on compounds targeting epigenetic machinery in cancer.
Main Results:
- Plant-derived compounds exhibit promising anticancer properties.
- These compounds interfere with key epigenetic mechanisms.
- Evidence suggests potential for chemoprevention and chemotherapy.
Conclusions:
- Epigenetic modifications are crucial in cancer development and progression.
- Plant-derived compounds offer a promising avenue for novel anticancer strategies.
- Targeting epigenetic machinery with natural compounds warrants further investigation.
More Related Videos
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...